A Consortium for Purchase of Blood Products Directed by Physicians

  1. LOUIS M. ALEDORT, M.D.;
  2. RICHARD A. LIPTON, M.D.; and
  3. MARGARET HILGARTNER, M.D.
  1. New York and New Hyde Park, New York

    Abstract

    Clotting-factor therapy is a costly part of comprehensive hemophilia treatment. Physicians treating patients with hemophilia in New York formed a consortium for the purchasing and regional distribution of clotting-factor concentrates. Concentrates are centrally purchased based on a bidding formula aimed at obtaining the lowest price for quality product while guaranteeing all suppliers continued involvement in a large market area. The consortium has successfully maintained, and, in instances, lowered prices each year. Estimated regional savings this year are more than $750 000 for an anticipated purchase of approximately 60 000 000 units of clotting-factors VIII and IX. Central distribution has additionally lowered costs to participating hospitals. The consortium is able to provide patients and third-party payers with some of the lowest prices for clotting-factor concentrates in the United States. A physician-directed regional approach to purchasing costly medical products might be applied to other areas of clinical medicine.

    Article and Author Information

    • ▸From the Mt. Sinai Medical Center, New York; the Long Island Jewish Medical Center, New Hyde Park; and the Cornell University Medical Center, New York, New York.

    • Grant support: in part by the National Heart, Lung, and Blood Institute, Bethesda, MD; Health Services Administration grant MCB-360001-04-01; Health and Human Services Grant HL-30567-02; the Regional Comprehensive Hemophilia Diagnostic and Treatment Center; the Margie Boas Fund; the International Hemophilia Training Center of the World Federation of Hemophilia; and the Polly Annenberg Levee Hematology Center, Department of Medicine, Mt. Sinai School of Medicine of the City University of New York, New York, New York.

    • ▸ Requests for reprints should be addressed to Louis M. Aledort, M.D.; Mt. Sinai Medical Center, Department of Medicine, 1 Gustave L. Levy Place; New York, NY 10029-6574.

    « Previous | Next Article »Table of Contents